Analyst Ratings for BlossomHill Therapeutics (BLSM)
BLSM Rating Summary
BLSM Price Target Summary
- Highest: $40.00 (Guggenheim)
- Lowest: $28.00 (JPMorgan)
- Average: $33.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$33.75 (+142.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$33.75 (+142.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/1/2026 | LifeSci Capital | N/A | New Coverage | Outperform (N/A) |
32.00 (N/A) |
18.30 (13.94) |
-23.83% | Details |
| 9/1/2026 | H.C. Wainwright » Updated 9/30/2026 |
Robert Burns | New Coverage | Buy (N/A) |
35.00 (N/A) |
18.30 (13.94) |
-23.83% | Details |
 |
||||||||
|
||||||||
